{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:51:42Z","timestamp":1787741502783,"version":"build-2784847793"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100005646","name":"Actelion Pharmaceuticals Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.wneu.2019.04.222","type":"journal-article","created":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T02:05:50Z","timestamp":1556762750000},"page":"e639-e648","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study"],"prefix":"10.1016","volume":"128","author":[{"given":"Randall T.","family":"Higashida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Bruder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdel","family":"Hmissi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Marr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan A.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9bastien","family":"Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Weidauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Fran\u00e7ois","family":"Aldrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2019.04.222_bib1","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1161\/STR.0b013e3182587839","article-title":"Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"43","author":"Connolly","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.04.222_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S1474-4422(09)70126-7","article-title":"Changes in case fatality of aneurysmal subarachnoid haemorrhage over time, according to age, sex, and region: a meta-analysis","volume":"8","author":"Nieuwkamp","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2019.04.222_bib3","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/B978-0-444-63600-3.00012-X","article-title":"Management of aneurysmal subarachnoid hemorrhage","volume":"140","author":"Etminan","year":"2017","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.wneu.2019.04.222_bib4","first-page":"173","article-title":"Time course of vasospasm in man","volume":"48","author":"Weir","year":"1978","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.04.222_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fneur.2014.00072","article-title":"Treatment of intracranial vasospasm following subarachnoid hemorrhage","volume":"5","author":"Bauer","year":"2014","journal-title":"Front Neurol"},{"key":"10.1016\/j.wneu.2019.04.222_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1017\/cjn.2015.288","article-title":"Cerebral vasospasm: a review","volume":"43","author":"Findlay","year":"2016","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.wneu.2019.04.222_bib7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1056\/NEJM198303173081103","article-title":"Cerebral arterial spasm\u2014a controlled trial of nimodipine in patients with subarachnoid hemorrhage","volume":"308","author":"Allen","year":"1983","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.wneu.2019.04.222_bib8","first-page":"505","article-title":"Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial","volume":"68","author":"Petruk","year":"1988","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.04.222_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12028-010-9442-2","article-title":"Bedside use of a dual aortic balloon occlusion for the treatment of cerebral vasospasm","volume":"13","author":"Appelboom","year":"2010","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2019.04.222_bib10","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3174\/ajnr.A1005","article-title":"Intra-arterial nimodipine for severe cerebral vasospasm after aneurysmal subarachnoid hemorrhage: influence on clinical course and cerebral perfusion","volume":"29","author":"Hanggi","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2019.04.222_bib11","first-page":"1284","article-title":"Intraarterially administered verapamil as adjunct therapy for cerebral vasospasm: safety and 2-year experience","volume":"23","author":"Feng","year":"2002","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.wneu.2019.04.222_bib12","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s10286-004-0186-y","article-title":"Endothelin receptor antagonists and cerebral vasospasm","volume":"14","author":"Zimmermann","year":"2004","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.wneu.2019.04.222_bib13","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1161\/STROKEAHA.108.519942","article-title":"Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial","volume":"39","author":"Macdonald","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.04.222_bib14","first-page":"9","article-title":"Clazosentan (axv-034343), a selective endothelin a receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIA study","volume":"103","author":"Vajkoczy","year":"2005","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.wneu.2019.04.222_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s12028-011-9605-9","article-title":"Critical care management of patients following aneurysmal subarachnoid hemorrhage: recommendations from the Neurocritical Care Society's multidisciplinary consensus conference","volume":"15","author":"Diringer","year":"2011","journal-title":"Neurocrit Care"},{"key":"10.1016\/j.wneu.2019.04.222_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s00234-004-1281-4","article-title":"Assessment of changes in cerebral circulation time due to vasospasm in a specific arterial territory: effect of angioplasty","volume":"47","author":"Turowski","year":"2005","journal-title":"Neuroradiology"},{"key":"10.1016\/j.wneu.2019.04.222_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(89)90015-9","article-title":"Optimal two-stage designs for phase II clinical trials","volume":"10","author":"Simon","year":"1989","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.wneu.2019.04.222_bib18","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","article-title":"Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2)","volume":"10","author":"Macdonald","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.wneu.2019.04.222_bib19","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1161\/STROKEAHA.111.648980","article-title":"Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling","volume":"43","author":"Macdonald","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.04.222_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000475824","article-title":"Preventive effect of clazosentan against cerebral vasospasm after clipping surgery for aneurysmal subarachnoid hemorrhage in Japanese and Korean patients","volume":"44","author":"Fujimura","year":"2017","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.wneu.2019.04.222_bib21","first-page":"272","article-title":"Clazosentan (Actelion)","volume":"7","author":"Uhlmann","year":"2006","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.wneu.2019.04.222_bib22","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1161\/01.STR.0000126039.91400.cb","article-title":"Direct observation of the human cerebral microcirculation during aneurysm surgery reveals increased arteriolar contractility","volume":"35","author":"Pennings","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.wneu.2019.04.222_bib23","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/ncpneuro0490","article-title":"Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution","volume":"3","author":"Macdonald","year":"2007","journal-title":"Nat Clin Pract Neurol"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019312185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875019312185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:30:49Z","timestamp":1761813049000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875019312185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":23,"alternative-id":["S1878875019312185"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2019.04.222","relation":{},"ISSN":["1878-8750"],"issn-type":[{"value":"1878-8750","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reversal of Vasospasm with Clazosentan After Aneurysmal Subarachnoid Hemorrhage: A Pilot Study","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2019.04.222","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}